Target intelligence / Profile preview

Parasite deoxyribonucleic acid (DNA) (DNA)

Target
DNA
Molecular classification
Nucleic acid
01

Overview

Parasite deoxyribonucleic acid (DNA) is the fundamental genetic material of parasitic organisms, including protozoa and helminths, and serves as a primary target for several classes of antiparasitic drugs. It encompasses nuclear DNA as well as specialized organellar DNA, such as the kinetoplast DNA (kDNA) in trypanosomatids and the apicoplast DNA in apicomplexans. Therapeutic agents target parasite DNA through various mechanisms, including minor groove binding, intercalation, and the generation of reactive radicals that induce lethal strand breaks. For instance, diamidines like pentamidine bind to AT-rich regions of the minor groove, while nitroimidazoles like metronidazole are reduced to toxic intermediates that damage the DNA structure. These interactions disrupt essential processes such as DNA replication and transcription, ultimately leading to the cessation of parasite growth and cell death. The selectivity of these drugs often relies on the unique composition of parasite genomes or the presence of specific metabolic pathways for drug activation that are absent in the host. Despite their efficacy, the use of DNA-targeting drugs is often limited by concerns regarding host genotoxicity and the rapid development of resistance through genetic mutations.

Other names
Parasitic DNAProtozoal DNAHelminth DNAKinetoplast DNAkDNAApicoplast DNA
02

Mechanism of action

DNA intercalation, minor groove binding, induction of DNA strand breaks via reactive radicals, and inhibition of DNA replication and transcription.

03

Biological functions

Genetic information storageDNA replicationTranscriptionTranslationMitochondrial function
04

Disease associations

Infection
05

Safety considerations

GenotoxicityMutagenicityNeurotoxicityNephrotoxicityDevelopment of drug resistance
06

Interacting drugs

Metronidazole

8 more in the full profile.

07

Biomarkers

Parasite DNA levels (PCR/qPCR)ParasitemiaCirculating parasite DNA (cpDNA)

Beyond the preview

Go deeper on Parasite deoxyribonucleic acid (DNA) (DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Parasite deoxyribonucleic acid (DNA) (DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call